Evolent Health Names Archie Mayani as New Chief Product Officer to Enhance Product Strategy Evolent Health has appointed Archie Mayani as chief product officer, bringing her extensive experience in healthcare technology and AI innovation to improve product offerings.

Evolent Health Names Archie Mayani as New Chief Product Officer to Enhance Product Strategy #USA #Washington #Health_Technology #Evolent_Health #Archie_Mayani

Evolent Health Reports Strong Financial Performance for 2025, Anticipates Significant Growth in 2026 Evolent Health has revealed its financial outcomes for Q4 and full year 2025, showcasing a revenue increase and insights into expected growth for 2026. The CEO highlights strong market presence and strategies for enhanced profitability.

Evolent Health Reports Strong Financial Performance for 2025, Anticipates Significant Growth in 2026 #USA #Washington #Evolent_Health #NYSE_EVH #Health_Care_Solutions

Evolent Health Grants Inducement Award Following New CFO Appointment Evolent Health announces a significant stock award for new CFO Mario Ramos under NYSE Rule 303A.08, reflecting its commitment to excellence.

Evolent Health Grants Inducement Award Following New CFO Appointment #United_States #Washington #Mario_Ramos #Evolent_Health #CFO_Inducement

Evolent Health Reports Strong Q3 2025 Results with New Revenue Growth Projections Evolent Health has announced its Q3 2025 results, exceeding expectations with new revenue contracts anticipated to add up to $750 million in 2026.

Evolent Health Reports Strong Q3 2025 Results with New Revenue Growth Projections #United_States #Washington,_D.C. #Evolent_Health #Performance_Suite #Oncology_Care_Partners

Evolent and American Oncology Network: A Revolutionary Step Towards Streamlined Cancer Care Evolent Health and American Oncology Network launch a groundbreaking model to enhance cancer care without prior authorization, improving patient outcomes.

Evolent and American Oncology Network: A Revolutionary Step Towards Streamlined Cancer Care #Cancer_Care #Evolent_Health #American_Oncology_Network

Evolent Health's Strategic Sale Enhances Focus and Cash Flow Management Evolent Health announces the strategic sale of its value-based primary care unit, improving focus on specialty care and enhancing cash flow post-transaction.

Evolent Health's Strategic Sale Enhances Focus and Cash Flow Management #USA #Washington #Evolent_Health #Evolent_Care_Partners #Privia_Health

Evolent Health, Inc. Announce Successful Upsizing of Convertible Senior Notes Worth $145 Million Evolent Health has announced the pricing of $145 million convertible senior notes to enhance market performance and repurchase existing notes.

Evolent Health, Inc. Announce Successful Upsizing of Convertible Senior Notes Worth $145 Million #United_States #Washington #Convertible_Notes #Class_A_Common_Stock #Evolent_Health

Evolent Health Proposes $140 Million Offering of Convertible Notes Due 2031 for Debt and Stock Repurchase Evolent Health, Inc. announces a proposed offering of $140 million in convertible senior notes to repurchase existing debt and its Class A common stock, enhancing financial health.

Evolent Health Proposes $140 Million Offering of Convertible Notes Due 2031 for Debt and Stock Repurchase #United_States #Washington #Convertible_Notes #Class_A_Common_Stock #Evolent_Health

Evolent Health Reports Key Financial Insights for Q2 2025 Evolent Health, a frontrunner in complex care solutions, shares its financial performance for Q2 2025, showcasing a focus on enhancing healthcare affordability and quality.

Evolent Health Reports Key Financial Insights for Q2 2025 #USA #Washington #financial_results #Evolent_Health #Complex_Care

Evolent Health Expands Leadership Team with Key Appointments to Advance Specialty Care Evolent Health announces the recruitment of Dr. David Lim as chief clinical officer and John Way as CFO to enhance its commitment to better health outcomes.

Evolent Health Expands Leadership Team with Key Appointments to Advance Specialty Care #USA #Washington #Evolent_Health #Dr._David_Lim #John_Way

Evolent Health Confirms Q2 and Full-Year Adjusted EBITDA Projections Amidst Strong Business Trends Evolent Health maintains its Adjusted EBITDA expectations for Q2 and the full year, citing positive oncology trends and enhanced revenue forecasts for 2026.

Evolent Health Confirms Q2 and Full-Year Adjusted EBITDA Projections Amidst Strong Business Trends #USA #Washington #Evolent_Health #Adjusted_EBITDA #John_Johnson

Evolent Health Reports Strong Q1 2025 Results Amid Growth in Innovative Care Solutions Evolent Health achieved impressive results in Q1 2025, while expanding its innovative care solutions. The growth is driven by strong partnerships and financial performance.

Evolent Health Reports Strong Q1 2025 Results Amid Growth in Innovative Care Solutions #USA #Washington #Healthcare_Solutions #Evolent_Health #Oncology_Management

Evolent Health Appoints Shawn Guertin as New Nominee for Board of Directors Ahead of Annual Election Evolent Health has announced the nomination of Shawn Guertin for its Board of Directors, marking an important step in their ongoing board refreshment efforts.

Evolent Health Appoints Shawn Guertin as New Nominee for Board of Directors Ahead of Annual Election #United_States #Washington #Board_of_Directors #Evolent_Health #Shawn_Guertin

Evolent Health's Program Reduces Low-Value Cancer Treatments by 20% Evolent Health has successfully reduced the use of low-value cancer treatments by over 20%, improving patient care and managing costs through innovative provider engagement strategies.

Evolent Health's Program Reduces Low-Value Cancer Treatments by 20% #USA #Washington #Cancer_Treatments #Evolent_Health #oncology_regimens

Evolent Health Reports Significant Fourth Quarter 2024 Financial Results Showcasing Continued Growth Evolent Health's recent financial results indicate impressive growth, with substantial revenue increase despite challenges faced in the healthcare sector.

Evolent Health Reports Significant Fourth Quarter 2024 Financial Results Showcasing Continued Growth #USA #healthcare #Washington #Financial_Growth #Evolent_Health

Evolent Health Announces Board of Directors Changes and New Leadership Plans for 2025 Evolent Health has announced significant changes to its Board of Directors, including Rick Jelinek as the new Chair to enhance governance and shareholder collaboration.

Evolent Health Announces Board of Directors Changes and New Leadership Plans for 2025 #United_States #Washington #Evolent_Health #Rick_Jelinek #Brendan_Springstubb

Evolent Health Welcomes Dr. Von Nguyen as Chief Medical Officer Starting January 1, 2025 Evolent Health has announced that Dr. Von Nguyen will take on the role of Chief Medical Officer beginning January 1, 2025, succeeding Dr. Andrew Hertler.

Evolent Health Welcomes Dr. Von Nguyen as Chief Medical Officer Starting January 1, 2025 #United_States #Washington #Evolent_Health #Dr._Von_Nguyen #Chief_Medical_Officer